Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 1843142, 7 pages
https://doi.org/10.1155/2018/1843142
Review Article

A Review of Ginseng Clinical Trials Registered in the WHO International Clinical Trials Registry Platform

Center for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China

Correspondence should be addressed to Jihan Huang; nc.ude.mctuhs@nahijgnauh

Received 18 October 2017; Revised 30 December 2017; Accepted 4 January 2018; Published 6 February 2018

Academic Editor: Kumud K. Kafle

Copyright © 2018 Yingchun He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. FM, “Panax ginseng. Monograph,” Alternative Medicine Review, vol. 14, no. 2, pp. 172–176, 2009. View at Google Scholar
  2. L. FC, Facts about ginseng: the elixir of life, Hollyn International Corporation, Elizabeth, NJ, USA, 1992.
  3. II. Brekhman and IV. Dardymov, “New substances of plant origin which increase nonspecific resistance,” Annual Review of Pharmacology, vol. 9, pp. 419–430, 1969. View at Google Scholar
  4. M. K. Ang-Lee, J. Moss, and C. S. Yuan, “Herbal medicines and perioperative care,” Jama, vol. 286, no. 2, pp. 208–216, 2001. View at Google Scholar
  5. J.-F. Cui, “Identification and quantification of ginsenosides in various commercial ginseng preparations,” European Journal of Pharmaceutical Sciences, vol. 3, no. 2, pp. 77–85, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Firenzuoli and L. Gori, “Herbal medicine today: clinical and research issues,” Evidence-Based Complementary and Alternative Medicine, vol. 4, supplement 1, pp. 37–40, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Chen, Z. Wang, and Y. Huang, “Ginseng and anticancer drug combination to improve cancer chemotherapy: a critical review,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 168940, 13 pages, 2014. View at Publisher · View at Google Scholar
  8. B. Sibbald and M. Roland, “Understanding controlled trials: Why are randomised controlled trials important?” BMJ, vol. 316, no. 7126, p. 201, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. WHO, “International Clinical Trials Registry Platform,” http://apps.who.int/trialsearch/.
  10. N. A. Khan, M. Singh, H. J. Spencer, and K. D. Torralba, “Randomized controlled trials of rheumatoid arthritis registered at clinicaltrials.gov: What gets published and when,” Arthritis & Rheumatology, vol. 66, no. 10, pp. 2664–2673, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. B. K. Vogler, M. H. Pittler, and E. Ernst, “The efficacy of ginseng. A systematic review of randomised clinical trials,” European Journal of Clinical Pharmacology, vol. 55, no. 8, pp. 567–575, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. D.-J. Jang, M. S. Lee, B.-C. Shin, Y.-C. Lee, and E. Ernst, “Red ginseng for treating erectile dysfunction: a systematic review,” British Journal of Clinical Pharmacology, vol. 66, no. 4, pp. 444–450, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Soo-Jin, C. Yang-Jin, P. Jae-Ho, and H. Hee-Do, “Meta-analysis of studies and patents on Korean ginseng in recent 5 years in Korea and prospective needs,” Journal of Ginseng Research, vol. 30, pp. 212–219, 2006. View at Google Scholar
  14. C. Buettner, G. Y. Yeh, R. S. Phillips, M. A. Mittleman, and T. J. Kaptchuk, “Systematic review of the of ginseng on cardiovascular risk factors,” Annals of Pharmacotherapy, vol. 40, no. 1, pp. 83–95, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Choi, TH. Kim, TY. Choi, and MS. Lee, “Ginseng for health care: a systematic review of randomized controlled trials in Korean literature,” PLoS One, vol. 8, no. 4, p. e59978, 2013. View at Google Scholar
  16. M. S. Lee, E. J. Yang, J.-I. Kim, and E. Ernst, “Ginseng for cognitive function in alzheimer's disease: A systematic review,” Journal of Alzheimer's Disease, vol. 18, no. 2, pp. 339–344, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. L. Shergis, A. L. Zhang, W. Zhou, and C. C. Xue, “Panax ginseng in Randomised controlled trials: A systematic review,” Phytotherapy Research, vol. 27, no. 7, pp. 949–965, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. N.-H. Lee and C.-G. Son, “Systematic review of randomized controlled trials evaluating the efficacy and safety of ginseng,” JAMS Journal of Acupuncture and Meridian Studies, vol. 4, no. 2, pp. 85–97, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Young-Sook, W. Jung-Yoon, H. Chang-Kyun, and C. Il-Moo, “Safety analysis of panax ginseng in randomized clinical trials: a systematic review,” Medicines, vol. 8, no. 2, pp. 106–126, 2015. View at Google Scholar
  20. J. K. Seida, T. Durec, and S. Kuhle, “North american (panax quinquefolius) and asian ginseng (panax ginseng) preparations for prevention of the common cold in healthy adults: a systematic review,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, p. 282151, 2011. View at Google Scholar
  21. I.-H. Baeg and S.-H. So, “The world ginseng market and the ginseng (Korea),” Journal of Ginseng Research, vol. 37, no. 1, pp. 1–7, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. R. M. Califf, D. A. Zarin, J. M. Kramer et al., “Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010,” Jama, vol. 307, no. 17, pp. 1838–1847, 2012. View at Google Scholar
  23. C. Stockmann, C. M. T. Sherwin, G. Koren et al., “Characteristics and publication patterns of obstetric studies registered in ClinicalTrials.gov,” Clinical Pharmacology and Therapeutics, vol. 54, no. 4, pp. 432–437, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Gandhi, M. Jan, H. N. Smith, N. N. Mahomed, and M. Bhandari, “Comparison of published orthopaedic trauma trials following registration in Clinicaltrials.gov,” BMC Musculoskeletal Disorders, vol. 12, article no. 278, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Wildt, A. Krag, and L. Gluud, “Characteristics of randomised trials on diseases in the digestive system registered in ClinicalTrials.gov: A retrospective analysis,” BMJ Open, vol. 1, no. 2, p. e000309, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. J. S. Ross, T. Tse, D. A. Zarin, H. Xu, L. Zhou, and H. M. Krumholz, “Publication of NIH funded trials registered in ClinicalTrials.gov: Cross sectional analysis,” BMJ, vol. 344, no. 7838, p. d7292, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. A. T. McCray and N. C. Ide, “Design and implementation of a national clinical trials registry,” Journal of the American Medical Informatics Association , vol. 7, no. 3, pp. 313–323, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Yusuf, R. Collins, and R. Peto, “Why do we need some large, simple randomized trials?” Statistics in Medicine, vol. 3, no. 4, pp. 409–420, 1984. View at Publisher · View at Google Scholar · View at Scopus
  29. R. M. Califf and D. L. DeMets, “Principles from clinical trials relevant to clinical practice: Part I,” Circulation, vol. 106, no. 8, pp. 1015–1021, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. E. PD, The essential guide to effect sizes: Statistical power, meta-analysis, and the interpretation of research results, Cambridge University Press, 2010.
  31. F. Wahid, T. Khan, F. Subhan, M. A. Khan, and Y. Y. Kim, “Ginseng pharmacology: Multiple molecular targets and recent clinical trials,” Drugs of the Future, vol. 35, no. 5, pp. 399–407, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. L. E. Liberti and A. D. Marderosian, “Evaluation of commercial ginseng products,” Journal of Pharmaceutical Sciences, vol. 67, no. 10, pp. 1487–1489, 1978. View at Publisher · View at Google Scholar · View at Scopus
  33. P. JD and A. LA, “Ginseng, quality, safety and efficiency,” Pharmaceutical Journal, vol. 232, pp. 161–165, 1984. View at Google Scholar
  34. D. Ogino, K. Takahashi, and H. Sato, “Characteristics of clinical trial websites: information distribution between ClinicalTrials.gov and 13 primary registries in the WHO registry network,” Trials, vol. 15, p. 428, 2014. View at Google Scholar
  35. Y. S. Kim, J. Y. Woo, C. K. Han, and I. M. Chang, “Safety analysis of panax ginseng in randomized clinical trials: a systematic review,” Medicines (Basel), vol. 2, no. 2, pp. 106–126, 2015. View at Google Scholar